Weighing the Pros and Cons of Ozempic Alternatives for US Patients
The FDA has not approved Ozempic Alternatives US for weight loss, said Andrew Kraftson, a clinical associate professor in the division of metabolism, endocrinology and diabetes at Michigan Medicine. But, he explained, after the FDA approved Wegovy for weight loss, demand increased so much that some medical professionals turned to Ozempic Alternatives US when they couldn't get Wegovy.
Just as some people are prescribed medications for high blood pressure or high cholesterol indefinitely, some obese patients may be prescribed drugs like Wegovy for long periods, Kraftson said. Those who stop taking the drug may regain the weight they lost, he added.
“These drugs were not designed for normal-weight people who want to be super thin,” Hwang said.
Who should take Ozempic Alternatives US and Wegovy?
After the FDA approved Ozempic Alternatives US for people with type 2 diabetes, the agency approved Wegovy for adults who are obese or overweight with at least one “weight-related condition,” which the agency considers problems like high blood pressure, type 2 diabetes or high cholesterol. The FDA defines obesity and overweight using body mass index, a long-standing but hotly debated metric.
Without insurance, the drug is expensive: The list price for a 28-day supply of Wegovy is $1,300, and Ozempic Alternatives US can cost about $892 a month without insurance, and people who don't meet the FDA's criteria will undoubtedly have a hard time getting it covered by insurance.
Despite those hurdles, the rise in people using Ozempic Alternatives US off-label may be exacerbating the shortage, Narang said, noting that patients with diabetes and obesity have difficulty accessing the drug.
“It’s been very, very scary – patients don’t know where to go,” she said. “We’ve been like hamsters on a wheel trying to figure it out.”
- Username
- ozempic-alternatives-us
- Member Since
- 2024 जुलाई 19
- State
- active